Warning: This security is no longer trading.
Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics
Dimension Therapeutics, Inc. (DMTX): Price and Financial Metrics
DMTX Price/Volume Stats
| Current price | $5.95 | 52-week high | $6.10 |
| Prev. close | $5.97 | 52-week low | $1.05 |
| Day low | $5.95 | Volume | 27,700 |
| Day high | $6.00 | Avg. volume | 150,214 |
| 50-day MA | $5.31 | Dividend yield | N/A |
| 200-day MA | $2.53 | Market Cap | 150.00M |
DMTX Stock Price Chart Interactive Chart >
Dimension Therapeutics, Inc. (DMTX) Company Bio
Dimension Therapeutics, Inc. focuses on discovering and developing therapeutic products for people living with rare diseases associated with the liver and caused by genetic mutations. The company was founded in 2013 and is based in Cambridge, Massachusetts.
DMTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...